iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLLMichael Hallek, Thomas J. Kipps, Susan O’Brien et al.|Blood|2018Cited by 1.7k
Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic LeukemiaJohn F. Seymour, Arnon P. Kater, Guillaume Cartron et al.|New England Journal of Medicine|2018Cited by 907
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upBarbara Eichhorst, Christian Buske, Tadeusz Robak et al.|Annals of Oncology|2015Cited by 604
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upBarbara Eichhorst, Ulrich Mey, Tadeusz Robak et al.|Annals of Oncology|2020Cited by 568
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic LeukemiaJennifer R. Brown, Mazyar Shadman, Barbara Eichhorst et al.|New England Journal of Medicine|2022Cited by 453